SCHEMBL2136658

SCHEMBL2136658

COc1ccc(C(=O)c2ccc(OC)cc2C2CCCCN2C(=O)OC(C)(C)C)c(C2CCCCN2C(=O)OC(C)(C)C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43
▸ USP30 Q70CQ3 1/20 0.43
▸ STS P08842 2/20 0.42
▸ EPHX2 P34913 1/20 0.40
▸ MTNR1B P49286 1/20 0.40
▸ HTT P42858 2/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ HSP90AA1 P07900 2/20 0.39
▸ HSP90AB1 P08238 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ NPSR1 Q6W5P4 1/20 0.39
▸ GPR119 Q8TDV5 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2136662 1.00 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1RAB9AL3MBTL1
SCHEMBL2137749 1.00 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1RAB9AL3MBTL1
SCHEMBL2137742 1.00 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1RAB9AL3MBTL1
SCHEMBL2136674 1.00 ALDH1A1 (0.43) ALDH1A1KDM4ENPC1RAB9AL3MBTL1
SCHEMBL2136664 0.85 L3MBTL1 (0.49) ALDH1A1KDM4ENPC1RAB9AL3MBTL1
SCHEMBL2130465 0.82 MEN1 (0.46) ALDH1A1NPC1L3MBTL1MEN1KMT2A
SCHEMBL2130464 0.82 MEN1 (0.46) ALDH1A1NPC1L3MBTL1MEN1KMT2A
SCHEMBL2130474 0.82 MEN1 (0.46) ALDH1A1NPC1L3MBTL1MEN1KMT2A
SCHEMBL29585212 0.81 HSD17B10 (0.55) ALDH1A1KDM4ESTSHTTHSD17B10
SCHEMBL17151071 0.77 HSD17B10 (0.59) ALDH1A1KDM4ENPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9463187-B2 Methylphenidate derivatives and uses of them AMPIO PHARMACEUTICALS, INC. (US) 2016-10-11 — — US disclosed
US-20120101129-A1 Methylphenidate Derivatives and Uses of Them AMPIO PHARMACEUTICALS, INC. 2012-04-26 — — US disclosed
US-8076485-B2 Methylphenidate derivatives and uses of them INSTITUTE FOR MOLECULAR MEDICINE, INC. (US) 2011-12-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120101129-A1 Methylphenidate Derivatives and Uses of Them SLC6A3, COMT, UGT1A1 ALDH1A1 335/4885KDM4E 422/4885NPC1 390/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback